Sacubitril/valsartan treatment: effect on left ventricular remodelling and fibrosis assessed by novel heart failure biomarkers

26 August 2022 (15:15 - 16:00)
Organised by:
Congress Presentation Part of: Heart failure pharmacotherapy - Sacubitril/valsartan Ventricular Remodelling ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by